HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wong, T. Y. H. Articles by Lai, F. M.-M. Search for Related Content PubMed PubMed Citation Articles by Wong, T. Y. H. Articles by Lai, F. M.-M. Social Bookmarking                What's this?

Renal Outcome in Type 2 Diabetic Patients With or Without Coexisting Nondiabetic Nephropathies

¹ Department of Medicine and Therapeutics, the Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, China
² Department of Anatomical and Cellular Pathology, the Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, China
³ Department of Chemical Pathology, the Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, China

OBJECTIVE—To determine the risk factors for adverse renal outcome in type 2 diabetic patients who underwent renal biopsy and were followed-up longitudinally.

RESEARCH DESIGN AND METHODS—We examined 68 consecutive patients with type 2 diabetes during the period of 1985–1999 who underwent renal biopsy for proteinuria 1 g/day, renal involvement (proteinuria or renal impairment) at the absence of retinopathy, renal involvement with duration of diabetes <5 years, or unexplained hematuria of glomerular origin. Their clinical features and underlying renal lesion were correlated with the renal outcome after longitudinal follow-up. Three groups of patients were defined based on their renal pathology: group I consisted of 24 patients (35%) with diabetic glomerulosclerosis (DGS) alone, group II consisted of 13 patients (19%) with nondiabetic nephropathy (NDN) superimposed on DGS, and group III consisted of 31 patients (46%) with NDN alone without evidence of DGS.

RESULTS—After a mean follow-up of 123 months from the diagnosis of type 2 diabetes (74 months from the time of renal biopsy), univariate analysis showed that risk factors for reaching end-stage renal disease (requiring maintenance dialysis, or a serum creatinine [SCr] 700 µmol/l) included proteinuria 2 g/day (P = 0.0087), SCr >120 µmol/l (P = 0.0005), presence of retinopathy (P < 0.00001) at the time of biopsy, and biopsy showing DGS (groups I and II) (P = 0.035). On multivariate analysis, retinopathy was the only independent variable correlated with end-stage renal failure. This study also showed that the association of hematuria or proteinuria with the absence of retinopathy constitutes the strongest indication for a nondiabetic lesion (positive predictive values of 94%).

CONCLUSIONS—Patients with type 2 diabetes undergoing renal biopsy constitute a heterogeneous group by their clinical presentations and underlying pathology, but longitudinal studies on the renal outcome of these patients remain limited. Our study showed that renal biopsy is indicated in selective diabetic patients because of potentially treatable nephropathy and of a better prognosis than DGS.

Abbreviations: DGS, diabetic glomerulosclerosis • ESRF, end-stage renal failure • FGS, primary focal sclerosis • MCN, minimal change nephropathy • NDN, nondiabetic nephropathy • SCr, serum creatinine • TGF, transforming growth factor

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. H. Nasr, V. D. D'Agati, S. M. Said, M. B. Stokes, G. B. Appel, A. M. Valeri, and G. S. Markowitz Pauci-immune Crescentic Glomerulonephritis Superimposed on Diabetic Glomerulosclerosis Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1282 - 1288. [Abstract] [Full Text] [PDF]

				S. Krag, J. R. Nyengaard, and L. Wogensen Combined effects of moderately elevated blood glucose and locally produced TGF-{beta}1 on glomerular morphology and renal collagen production Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2485 - 2496. [Abstract] [Full Text] [PDF]

				C. K. Kramer, C. B. Leitao, L. C. Pinto, S. P. Silveiro, J. L. Gross, and L. H. Canani Clinical and Laboratory Profile of Patients With Type 2 Diabetes With Low Glomerular Filtration Rate and Normoalbuminuria Diabetes Care, August 1, 2007; 30(8): 1998 - 2000. [Full Text] [PDF]

				J. L. Gross, M. J. de Azevedo, S. P. Silveiro, L. H. Canani, M. L. Caramori, and T. Zelmanovitz Diabetic Nephropathy: Diagnosis, Prevention, and Treatment Diabetes Care, January 1, 2005; 28(1): 164 - 176. [Abstract] [Full Text] [PDF]

				G. H. Heine, U. Sester, M. Girndt, and H. Kohler Acanthocytes in the Urine: Useful tool to differentiate diabetic nephropathy from glomerulonephritis? Diabetes Care, January 1, 2004; 27(1): 190 - 194. [Abstract] [Full Text] [PDF]

				Y. Wang, M. C.Y. Ng, S.-C. Lee, W.-Y. So, P. C.Y. Tong, C. S. Cockram, J. A.J.H. Critchley, and J. C.N. Chan Phenotypic Heterogeneity and Associations of Two Aldose Reductase Gene Polymorphisms With Nephropathy and Retinopathy in Type 2 Diabetes Diabetes Care, August 1, 2003; 26(8): 2410 - 2415. [Abstract] [Full Text] [PDF]